Cargando…
BNT162b2 mRNA COVID‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection, but recognition of mutant viruses is up to 10‐fold reduced
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222933/ https://www.ncbi.nlm.nih.gov/pubmed/33948956 http://dx.doi.org/10.1111/all.14893 |
| _version_ | 1783711588935532544 |
|---|---|
| author | Chang, Xinyue Augusto, Gilles Sousa Liu, Xuelan Kündig, Thomas M. Vogel, Monique Mohsen, Mona O. Bachmann, Martin F. |
| author_facet | Chang, Xinyue Augusto, Gilles Sousa Liu, Xuelan Kündig, Thomas M. Vogel, Monique Mohsen, Mona O. Bachmann, Martin F. |
| author_sort | Chang, Xinyue |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8222933 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82229332021-06-25 BNT162b2 mRNA COVID‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection, but recognition of mutant viruses is up to 10‐fold reduced Chang, Xinyue Augusto, Gilles Sousa Liu, Xuelan Kündig, Thomas M. Vogel, Monique Mohsen, Mona O. Bachmann, Martin F. Allergy Letters to the Editor John Wiley and Sons Inc. 2021-05-20 2021-09 /pmc/articles/PMC8222933/ /pubmed/33948956 http://dx.doi.org/10.1111/all.14893 Text en © 2021 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Chang, Xinyue Augusto, Gilles Sousa Liu, Xuelan Kündig, Thomas M. Vogel, Monique Mohsen, Mona O. Bachmann, Martin F. BNT162b2 mRNA COVID‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection, but recognition of mutant viruses is up to 10‐fold reduced |
| title | BNT162b2 mRNA COVID‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection, but recognition of mutant viruses is up to 10‐fold reduced |
| title_full | BNT162b2 mRNA COVID‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection, but recognition of mutant viruses is up to 10‐fold reduced |
| title_fullStr | BNT162b2 mRNA COVID‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection, but recognition of mutant viruses is up to 10‐fold reduced |
| title_full_unstemmed | BNT162b2 mRNA COVID‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection, but recognition of mutant viruses is up to 10‐fold reduced |
| title_short | BNT162b2 mRNA COVID‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection, but recognition of mutant viruses is up to 10‐fold reduced |
| title_sort | bnt162b2 mrna covid‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection, but recognition of mutant viruses is up to 10‐fold reduced |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222933/ https://www.ncbi.nlm.nih.gov/pubmed/33948956 http://dx.doi.org/10.1111/all.14893 |
| work_keys_str_mv | AT changxinyue bnt162b2mrnacovid19vaccineinducesantibodiesofbroadercrossreactivitythannaturalinfectionbutrecognitionofmutantvirusesisupto10foldreduced AT augustogillessousa bnt162b2mrnacovid19vaccineinducesantibodiesofbroadercrossreactivitythannaturalinfectionbutrecognitionofmutantvirusesisupto10foldreduced AT liuxuelan bnt162b2mrnacovid19vaccineinducesantibodiesofbroadercrossreactivitythannaturalinfectionbutrecognitionofmutantvirusesisupto10foldreduced AT kundigthomasm bnt162b2mrnacovid19vaccineinducesantibodiesofbroadercrossreactivitythannaturalinfectionbutrecognitionofmutantvirusesisupto10foldreduced AT vogelmonique bnt162b2mrnacovid19vaccineinducesantibodiesofbroadercrossreactivitythannaturalinfectionbutrecognitionofmutantvirusesisupto10foldreduced AT mohsenmonao bnt162b2mrnacovid19vaccineinducesantibodiesofbroadercrossreactivitythannaturalinfectionbutrecognitionofmutantvirusesisupto10foldreduced AT bachmannmartinf bnt162b2mrnacovid19vaccineinducesantibodiesofbroadercrossreactivitythannaturalinfectionbutrecognitionofmutantvirusesisupto10foldreduced |